SCHEMBL21743333

SCHEMBL21743333

CCC(C)(C)NC(=N)N

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19636411 0.81
SCHEMBL18520505 0.81
SCHEMBL20365542 0.80 ALDH1A1 (0.47)
SCHEMBL12458682 0.80 ALDH1A1 (0.31)
SCHEMBL25015251 0.80
SCHEMBL17030121 0.79
SCHEMBL12091710 0.79 NOS1 (0.31)
SCHEMBL17975427 0.78 EPHX1 (0.38)
SCHEMBL20754289 0.77
Guanoctine SCHEMBL5909699 0.77 POLB (0.38)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230256047-A1 METHODS AND COMPOSITIONS FOR THE TREATMENT OF MUSCULAR DYSTROPHY STEALTH BIOTHERAPEUTICS INC. (US) 2023-08-17 US disclosed
EP-2970586-B1 AMINE FUNCTIONAL POLYAMIDES GENZYME CORP (US) 2022-12-07 EP disclosed
US-10874752-B2 MIBG analogs and uses thereof BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA (US) 2020-12-29 US disclosed
US-20200054741-A1 PEPTIDE-BASED VACCINES, METHODS OF MANUFACTURING, AND USES THEREOF FOR INDUCING AN IMMUNE RESPONSE AVIDEA TECHNOLOGIES, INC. (US) 2020-02-20 US disclosed